This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
BPC 157 improved outcomes in stroke, schizophrenia symptoms, and spinal cord injuries in rats.
Why it matters
Understanding BPC 157's effects could lead to new treatments for serious brain and nerve conditions. Its potential to address multiple disorders makes it a significant focus for future research.
How the study worked
The study involved reviewing recent experiments on BPC 157's effects in rat models of various central nervous system disorders.
What this study cannot tell us
The study is based on animal models, and results may not directly translate to humans. Further research is needed to confirm efficacy and safety in human subjects.
Read the original research
Pentadecapeptide BPC 157 and the central nervous system.
Neural regeneration research, 17(3), 482-487
Citation
Vukojevic, Jakša; Milavić, Marija; Perović, Darko; Ilić, Spomenko; Čilić, Andrea Zemba; Đuran, Nataša; Štrbe, Sanja; Zoričić, Zoran; Filipčić, Igor; Brečić, Petrana; Seiverth, Sven; Sikirić, Predrag. (2022). Pentadecapeptide BPC 157 and the central nervous system.. Neural regeneration research, 17(3), 482-487. https://doi.org/10.4103/1673-5374.320969